Anticorps Recombinant de lapin anti-Phospho-IkB Beta (Thr19/Ser23)

Phospho-IkB Beta (Thr19/Ser23) Recombinant Antibody for WB, FC (Intra), Indirect ELISA

Hôte / Isotype

Lapin / IgG

Réactivité testée

Humain

Applications

WB, FC (Intra), Indirect ELISA

Conjugaison

Non conjugué

CloneNo.

241061B2

N° de cat : 84403-1-PBS

Synonymes

IkB beta, IκB beta, IκB β, NFKBIB, IkB B



Informations sur le produit

84403-1-PBS cible Phospho-IkB Beta (Thr19/Ser23) dans les applications de WB, FC (Intra), Indirect ELISA et montre une réactivité avec des échantillons Humain

Réactivité Humain
Hôte / Isotype Lapin / IgG
Clonalité Recombinant
Type Anticorps
Immunogène Peptide
Nom complet nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, beta
Masse moléculaire calculée 356 aa, 38 kDa
Poids moléculaire observé 50 kDa
Numéro d’acquisition GenBankBC015528
Symbole du gène IkB Beta
Identification du gène (NCBI) 4793
Conjugaison Non conjugué
Forme Liquide
Méthode de purification Protein A purfication
Tampon de stockage PBS only
Conditions de stockageStore at -80°C. 20ul contiennent 0,1% de BSA.

Informations générales

IkB Beta is also named as NF-kappa-B inhibitor beta (NFKBIB) and TRIP-9. IKBB is one of the major isoforms of the NFKB inhibitor which preferentially interacts with c-Rel or p65 NF-kB dimers (PMID: 26227166). IKBB was reported to be associated with tumor growth inhibition and metastasis in lung cancer (PMID: 11402320). IKBB also inhibits cancer cell regulation through inactivation of the NFkB pathway (PMID: 18950638). Exposure of cells to a variety of extracellular stimuli leads to the rapid phosphorylation, ubiquitination, and ultimately proteolytic degradation of IkB, which frees NF-kB to translocate to the nucleus where it regulates gene transcription (PMID: 10837071). The antibody is phosphorylated at Thr19 and Ser23.

{{ptg:RelatedPrimaryAntibodies}}